| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |